GABAvsTaurine

GABA binds to GABA-A receptors (ligand-gated Cl- channels with alpha1-6, beta1-3, gamma1-3 subunits) and GABA-B receptors (G-protein coupled, Gi/o mediated), reducing neuronal excitability through hyperpolarization. However, supplemental GABA has limited blood-brain barrier penetration due to absence of a dedicated transporter and rapid metabolism by GABA-transaminase and succinate semialdehyde dehydrogenase in periphery. The calming effects may be mediated through: (1) GABA-A and GABA-B receptors in the enteric nervous system (gut-brain axis) — vagal afferents project to the nucleus tractus solitarius and influence limbic regions; (2) small amounts crossing the BBB via paracellular leakage or in individuals with compromised barrier integrity; (3) peripheral effects reducing systemic stress markers (cortisol, heart rate variability). PharmaGABA (Lactobacillus fermentation product) may have better absorption via peptide-like transport or different pharmacokinetics.

Taurine activates GABA-A receptors (particularly extrasynaptic δ-containing subtypes) and glycine receptors (GlyR) as a partial agonist, providing inhibitory modulation that reduces neural excitability and hyperexcitability. It acts as a powerful antioxidant, scavenging hypochlorous acid, hydroxyl radicals, and peroxynitrite in mitochondria and cytosol. Taurine regulates calcium homeostasis via modulation of ryanodine receptors and IP3 receptors, preventing excitotoxic calcium overload. It modulates osmotic balance through the taurine transporter (TauT/SLC6A6) to protect cells from swelling under stress. Taurine may enhance mitochondrial function and biogenesis. Recent research shows it maintains telomere length, reduces cellular senescence markers (p16, p21), and modulates the mTOR pathway.